Patents by Inventor Xueyan Wang

Xueyan Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160324812
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Application
    Filed: June 2, 2016
    Publication date: November 10, 2016
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • Publication number: 20160324811
    Abstract: The present invention provides methods for increasing LDL particle size.
    Type: Application
    Filed: January 13, 2016
    Publication date: November 10, 2016
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: David Karpf, Ronald M. Krauss, Yun-Jung Choi, Xueyan Wang, Francine M. Gregoire
  • Publication number: 20160233840
    Abstract: A sensor control circuit comprises a sensor (201), a filtering circuit (202), a buffering circuit (203), and an amplifying circuit (204). An output end of the sensor (201) is connected to an input end of the filtering circuit (202), an output end of the filtering circuit (202) is connected to an input end of the buffering circuit (203), and an output end of the buffering circuit (203) is connected to an input end of the amplifying circuit (204). Because the buffering circuit (203) is disposed between the filtering circuit (202) and the amplifying circuit (204), the sensor circuit has an advantage of full sampling. Further provided is an electronic apparatus using the sensor control circuit.
    Type: Application
    Filed: December 1, 2014
    Publication date: August 11, 2016
    Inventors: Xueyan Wang, Weiyan Zhang
  • Patent number: 9381181
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: July 5, 2016
    Assignee: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • Publication number: 20150290154
    Abstract: Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
    Type: Application
    Filed: April 10, 2015
    Publication date: October 15, 2015
    Applicant: CymaBay Therapeutics, Inc.
    Inventors: Brian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
  • Patent number: 8703776
    Abstract: Chemical compounds which act as agonists of, or otherwise modulate the activity of, GPR131 are disclosed. Related compositions, formulations and methods of use are also described.
    Type: Grant
    Filed: June 13, 2012
    Date of Patent: April 22, 2014
    Assignee: Cymabay Therapeutics, Inc.
    Inventors: Aaron Robert Novack, Dong-Fang Shi, Jingyuan Ma, Imad Nashashibi, Phuongly Pham, Jiangao Song, David W. G. Wone, Xueyan Wang, Jeffrey D. Johnson, Brian Edward Lavan, Charles A. McWherter, Xin Chen
  • Publication number: 20130059856
    Abstract: Chemical compounds which act as agonists of, or otherwise modulate the activity of, GPR131 are disclosed. Related compositions, formulations and methods of use are also described.
    Type: Application
    Filed: June 13, 2012
    Publication date: March 7, 2013
    Inventors: Aaron Robert Novack, Dong-Fang Shi, Jingyuan Ma, Imad Nashashibi, Phuongly Pham, Jiangao Song, David W. G. Wone, Xueyan Wang, Jeffrey D. Johnson, Brian Edward Lavan, Charles A. McWherter, Xin Chen
  • Publication number: 20100152295
    Abstract: The present invention provides methods for increasing LDL particle size.
    Type: Application
    Filed: October 15, 2009
    Publication date: June 17, 2010
    Applicant: Metabolex Inc.
    Inventors: David Karpf, Ronald M. Krauss, Yun-Jung Choi, Xueyan Wang, Francine M. Gregoire